AC IMMUNE SA Share Price Today: Live Updates & Key Insights
AC IMMUNE SA share price today is $2.45, up 1.72%. The stock opened at $2.345 against the previous close of $2.32, with an intraday high of $2.365 and low of $2.31.
AC IMMUNE SA Share Price Chart
AC IMMUNE SA
AC IMMUNE SA Share Price Performance
AC IMMUNE SA Institutional Holdings
AC IMMUNE SA Market Status
AC IMMUNE SA Fundamentals
Market Cap 236.11 M
PB Ratio 5.7755
PE Ratio 0.0
Enterprise Value 136.46 M
Total Assets 154.43 M
Volume 76946
AC IMMUNE SA Company Financials
About AC IMMUNE SA & investment objective
Company Information AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company's SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. It develops Crenezumab, a humanized, conformation specific monoclonal antibody used to slow Alzheimer's disease (AD) progression; and Semorinemab, an investigational monoclonal anti-Tau antibody that targets the N-terminal portion of the Tau protein and is designed to bind to Tau and slow its spread between neurons for the treatment of AD. The company is also developing ACI-24.060 for the treatment of down syndrome related AD; ACI-7104.056 to treat Parkinson's disease; and ACI-35.030, designs to stimulate a patient's immune system to produce antibodies against pathological phosphorylated Tau. In addition, it develops diagnostic programs consisting of PI-2620, a Tau diagnostic for AD, as well as non-AD Tauopathies; and ACI-12589 and ACI-15916, a-sync PET tracer that supports the differential diagnosis of multiple system atrophy from other neurodegenerative diseases. Further, the company is researching and developing Morphomer Tau aggregation inhibitors to evaluate candidates in AD; Morphomer a-syn to compete with small molecule inhibitors of a-syn aggregation; and NeuroOrphan Tauopathies. Additionally, it generates discovery and preclinical stage molecules targeting range of neurodegenerative diseases, which include diagnostics targeting TDP-43, alpha-synuclein, and NLRP3. The company has license agreements and collaborations with Genentech, Inc.; Janssen Pharmaceuticals, Inc.; Life Molecular Imaging SA; and Eli Lilly and Company. AC Immune SA was incorporated in 2003 and is headquartered in Lausanne, Switzerland.
Organisation Biotechnology
Employees 90
Industry Biotechnology
CEO Dr. Martin Zugel M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
AC IMMUNE SA FAQs
What is the share price of AC IMMUNE SA today?
The current share price of AC IMMUNE SA is $2.45.
Can I buy AC IMMUNE SA shares in India?
Yes, Indian investors can buy AC IMMUNE SA shares by opening an international trading and demat account with Motilal Oswal.
How to buy AC IMMUNE SA shares in India?
You can easily invest in AC IMMUNE SA shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy AC IMMUNE SA shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of AC IMMUNE SA.
Can I buy fractional shares of AC IMMUNE SA?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of AC IMMUNE SA?
AC IMMUNE SA has a market cap of $236.11 M.
In which sector does AC IMMUNE SA belong?
AC IMMUNE SA operates in the Biotechnology sector.
What documents are required to invest in AC IMMUNE SA stocks?
To invest, you typically need:
What is the PE and PB ratio of AC IMMUNE SA?
The PE ratio of AC IMMUNE SA is N/A and the PB ratio is 5.78.